OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Psychiatry is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Error in Table	770
Error in Quiz Answer	510
Viewing Psychiatric Epidemiology Within a Global Historical Framework to Shape Future Practice	503
Examining Sex Differences in Autism Heritability	427
Stress as a Risk Factor for Mental Disorders in a Gendered Environment	385
Coding Error for the Sex Variable in a Meta-analysis	316
Error in Race and Ethnicity Data	314
Change to Open Access Status	296
Characteristics of Registered Clinical Trials Evaluating the Role of e-Cigarettes in Cessation or Reduction of Cigarette Smoking	291
Bright Light Therapy for Nonseasonal Depressive Disorders—Reply	260
Psychiatric, Neurological, and Somatic Comorbidities in Intermittent Explosive Disorder	210
Sex and Drug Overdose Mortality Trends, 1999-2020—Reply	198
Mental Health Diagnoses in People Experiencing Homelessness—Reply	196
Social Vulnerability and Prevalence and Treatment for Mental Health and Substance Use Disorders	188
Population-Based Risk of Psychiatric Disorders Associated With Recurrent Copy Number Variants	186
Consistency of Delusion Themes Across First and Subsequent Episodes of Psychosis	172
Semaglutide in Psychiatry—Opportunities and Challenges	167
Effect of Culturally Tailored, Internet-Delivered Cognitive Behavioral Therapy for Insomnia in Black Women	165
Neuropsychiatric and Cognitive Outcomes in Patients 6 Months After COVID-19 Requiring Hospitalization Compared With Matched Control Patients Hospitalized for Non–COVID-19 Illness	164
Tax Policy—An Understudied Approach to Reducing Cannabis Use	163
Error in Text	156
Studying Healthy Psychosislike Experiences to Improve Illness Prediction	149
Changing Neighborhood Income Deprivation Over Time, Moving in Childhood, and Adult Risk of Depression	149
Insights on Neural Response to Racist Threats	146
How the Cognitive Science of Belief Can Transform the Study of Mental Health	135

Errors in Text and Table	133
Associating Violence With Schizophrenia—Risks and Biases	131
JAMA Psychiatry Editorial Fellow	128
Data Errors in Table	126
Some Concerns About Imputation Methods for Missing Data—Reply	124
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure—Reply	118
Psychiatric Medication Use After Possible Neuroborreliosis—Reply	118
Errors in Figure 4	115
Potential Limitations for Assessing Adverse Posttraumatic Neuropsychiatric Sequelae With Wrist-Wearable Device and Self-report Survey	104
JAMA Psychiatry	100
Association of Single-blind Placebo Run-in Periods With the Placebo Response in Randomized Clinical Trials of Antidepressants	99
JAMA Psychiatry	96
JAMA Psychiatry	96
The Direct Effect of Cognitive Behavioral Therapy for Insomnia on Depression Prevention and the Mediation Effect via Insomnia Remission	95
International Variation in Clozapine Hematologic Monitoring—A Call for Action	94
Effect of Escalating and Deescalating Financial Incentives vs Usual Care to Improve Antidepressant Adherence	93
Acceptability, Tolerability, and Estimates of Putative Treatment Effects of Probiotics as Adjunctive Treatment in Patients With Depression	91
Suicide Risk and Lithium	91
Further Considerations on Early Intervention for Borderline Personality Disorder—Reply	90
JAMA Psychiatry	89
Error in Additional Contributions	86
JAMA Psychiatry	86
SSRIs in Pregnancy—What Offspring Brain Volumes Can and Cannot Tell Us	84
The Reliability of Traumatic and Adverse Experiences	84
JAMA Psychiatry	82
Equity and the JAMA Network	80
Concerns About Data in Study Reporting an Association Between Abortion Restrictions and Suicide	80
Combination Antidepressant Therapy vs Monotherapy—Further Considerations	80
Error in Results	79
Estimated Number of Children Who Lost a Parent to Drug Overdose in the US From 2011 to 2021	77
Error in Text	77
Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression	75
Association of Multigenerational Family History of Depression With Lifetime Depressive and Other Psychiatric Disorders in Children	75
Another Effort to Get People With Mental Illness Experiencing Homelessness Off the Streets—A Sound Idea?	74
Evaluating the Liability of Antidepressants to Induce Mania in Children and Adolescents With Depression	73
Acknowledging Lack of Inclusion in Genetic Analyses—Reply	73
COP27 Climate Change Conference—Urgent Action Needed for Africa and the World	71
Healing Ethno-Racial Trauma in Black Communities	69
Deletion of Loss-of-Function–Intolerant Genes and Risk of 5 Psychiatric Disorders	69
Managerial and Organizational Challenges in the Age of AI	68
Charting New Phenomenological Paths for Empirical Research on Delusions	68
Trajectories of Adolescent Media Use and Their Associations With Psychotic Experiences	68
Race and Ethnicity of Editorial Board Members and Editors as an Indicator of Structural Racism in Psychiatry and Neuroscience Journals	66
The Subjective Experience of Childhood Maltreatment in Psychopathology	63
Differential Outcomes of Placebo Treatment Across 9 Psychiatric Disorders	63
Association of COVID-19 and Endemic Systemic Racism With Postpartum Anxiety and Depression Among Black Birthing Individuals	62
Associating Violence With Schizophrenia—Risks and Biases	62
Potential Lessons for DSM From Contemporary Philosophy of Science	62
Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	62
Errors in Numbers in Meta-Analysis	61

Pain Scores as Secondary Outcomes—Opioid Reduction Studies	61
Advancing Diversity, Equity, and Inclusion at JAMA Psychiatry	60
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death	59
Association Between Genetic Risk for Psychiatric Disorders and the Probability of Living in Urban Settings	59
Rethinking Palliative Care in Psychiatry	58
Is Anxiety in Late Life an Uncharted Territory?—Questioning the USPSTF Draft Recommendation Statement for Anxiety Screening in Older Adults	57
Inflammation and Brain Structure in Schizophrenia and Other Neuropsychiatric Disorders	57
Recommendation for Cannabis Use Disorder Diagnosis in a Context of Cannabis for Therapeutic Purposes	57
Methamphetamine Use, Methamphetamine Use Disorder, and Associated Overdose Deaths Among US Adults	56
Evaluation of Increases in Drug Overdose Mortality Rates in the US by Race and Ethnicity Before and During the COVID-19 Pandemic	56
Substance Use Disorder and Health Outcomes in COVID-19—The Need for a Better Research Method to Determine Substance Use Exposure	55
Association of US Nurse and Physician Occupation With Risk of Suicide	55
Assumptions and Limitations of the Synthetic Control Method	55
Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic	55
Setting Limits With Controlled Substances—The Role of Motivational Interviewing to Increase Comfort	54
Being Precise About Precision Mental Health	54
Alcohol Cue Processing in Co-Occurring Bipolar Disorder and Alcohol Use Disorder	54
Suicide Attempts of Muslims Compared With Other Religious Groups in the US	54
Ketamine vs Electroconvulsive Therapy for Major Depressive Episode	53
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging	53
Family History of Psychiatric Disorders as a Risk Factor for Maternal Postpartum Depression	52
Errors in Text and Supplement	52
Transcriptome-Wide Structural Equation Modeling of 13 Major Psychiatric Disorders for Cross-Disorder Risk and Drug Repurposing	52
Association of History of Psychopathology With Accelerated Aging at Midlife	52
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related Dementias	52
Moving Beyond Medications That Act at the μ Receptor in the Treatment of Opioid Use Disorder	52
Synaptic Density in Early Stages of Psychosis and Clinical High Risk	52
Clinical Outcomes of Continuation and Maintenance Electroconvulsive Therapy	51
Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia	51
Immediate and Sustained Outcomes and Moderators Associated With Metacognitive Training for Psychosis	51
Representation and Outcomes of Individuals With Schizophrenia Seen in Everyday Practice Who Are Ineligible for Randomized Clinical Trials	50
Left Ventrolateral Prefrontal Cortical Activity During Reward Expectancy and Mania Risk	50
Variations in Suicide Risk and Risk Factors After Hospitalization for Depression in Finland, 1996-2017	50
Driving Performance and Cannabis Users’ Perception of Safety	50
TikTok Challenges—Unintentional Injuries vs Suicide Attempts	49
Maternal Mental Health and Infant Development During the COVID-19 Pandemic	49
Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials	49
The Promise and Perils of Using Peers and Other Paraprofessionals as Mental Health Service Professionals	49
Changes in Attributable Fractions and Causal Inference for Schizophrenia and Other Psychiatric Outcomes	49
Neurocognitive Development in Children at Familial High Risk of Schizophrenia or Bipolar Disorder	47
Racial/Ethnic, Social, and Geographic Trends in Overdose-Associated Cardiac Arrests Observed by US Emergency Medical Services During the COVID-19 Pandemic	46
Effect of an Emergency Department Process Improvement Package on Suicide Prevention	46
Association of Comorbid Behavioral and Medical Conditions With Cannabis Use Disorder in Pregnancy	46
Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression	46
A Dynamical Systems View of Psychiatric Disorders—Practical Implications	46
Opportunities for Research on the Treatment of Substance Use Disorders in the Context of COVID-19	45
Timing of Antidepressant Discontinuation During Pregnancy and Postpartum Psychiatric Outcomes in Denmark and Norway	45
Associations Between Objective and Subjective Experiences of Childhood Maltreatment and the Course of Emotional Disorders in Adulthood	45
Prevalence and Trends in Suicidal Behavior Among US Military Veterans During the COVID-19 Pandemic	45
Cerebrospinal Fluid Biomarkers in Patients With Unipolar Depression Compared With Healthy Control Individuals	44
Can Sophisticated Study Designs With Regression Analyses of Observational Data Provide Causal Inferences?	44
Association of Brain Reward Response With Body Mass Index and Ventral Striatal-Hypothalamic Circuitry Among Young Women With Eating Disorders	44
Preaddiction—A Missing Concept for Treating Substance Use Disorders	43
Effort-Cost Decision-making Among Individuals With Schizophrenia	43
Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder	43
Combining Antidepressants vs Antidepressant Monotherapy for Treatment of Patients With Acute Depression	43
Reinforcement Learning Disruptions in Individuals With Depression and Sensitivity to Symptom Change Following Cognitive Behavioral Therapy	42
Quantifying Deviations of Brain Structure and Function in Major Depressive Disorder Across Neuroimaging Modalities	42
Does Microglial Activation Lead to Cognitive Changes After COVID-19 Infection?	42
Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities	42
Association of Oxidative Stress–Induced Nucleic Acid Damage With Psychiatric Disorders in Adults	41
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth	41
Components and Delivery Formats of Cognitive Behavioral Therapy for Chronic Insomnia in Adults	40
Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level	40
Patterns of Neural Network Functional Connectivity Associated With Mania/Hypomania and Depression Risk in 3 Independent Young Adult Samples	40
Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance	39
Posttraumatic Stress Disorder, Obesity, and Accelerated Epigenetic Aging Among US Military Veterans	39
US Religious Leaders’ Views on the Etiology and Treatment of Depression	39
Patterns of Brain Maturation in Autism and Their Molecular Associations	39
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia	39
Diagnosing and Treating ADHD in Adults	39
Considerations in Publishing a Psychiatric Randomized Clinical Trial With Kenyan Children	38
JAMA Psychiatry	38
Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode	38
JAMA Psychiatry—The Year in Review, 2020	38
Errors in Figure 2	38
Some Concerns About Imputation Methods for Missing Data	38
JAMA Psychiatry	37
Living Alone and Drug Overdose Deaths in the US	37
Errors From Incorrect Use of Subscale	37

Errors in a Response Rate and in Effect Sizes in Study of Psilocybin-Assisted Therapy for Major Depressive Disorder	36
Evolutionary Inquiries Into the Origin and Nature of Mental Disorders	36
Association of Frailty With Risk of Suicide Attempt in a National Cohort of US Veterans Aged 65 Years or Older	36
JAMA Psychiatry	35
Heritability of Psychotic Experiences in Adolescents and Interaction With Environmental Risk	35
Applying Anti-racism to Clinical Care and Research	34
Public Sector Learning Health Care Systems—Improving Patient Experience, Workforce Well-Being, and Recovery Outcomes	34
Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder	34
Error in Table 1	33
Multivariate, Transgenerational Associations of the COVID-19 Pandemic Across Minoritized and Marginalized Communities	33
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability—Reply	33
Error in Tables	32
Error in Author Name Presentation	32
Prevalence and Correlates of Suicide and Nonsuicidal Self-injury in Children	31
JAMA Psychiatry	30
Improving the Assessment of COVID-19–Associated Posttraumatic Stress Disorder	30
Challenges to Behavioral Health and Injury Surveillance During the COVID-19 Pandemic—Reply	30
Beyond Efficacy and Toward Dissemination and Personalization of Psychotherapy for Bipolar Disorder	30
Choosing Between Ketamine and Electroconvulsive Therapy for Outpatients With Treatment-Resistant Depression—Advantage Ketamine?	29
Dissimilar Control Interventions in Clinical Trials Undermine Interpretability	29
JAMA Psychiatry	29
Errors in Relative Risks Reported in Figure 3 in a Network Meta-analysis of Cognitive Behavior Therapy Delivery Formats in Adults With Depression	29
Association of Social Determinants of Health and Vaccinations With Child Mental Health During the COVID-19 Pandemic in the US	29
Cognitive Function in People With Familial Risk of Depression	29
Prefrontal γ-Aminobutyric Acid Levels in Never-Medicated Individuals With Chronic Schizophrenia	28
JAMA Network Call for Papers on Health and the 2024 US Election	28
Trends in Acute Care Use for Mental Health Conditions Among Youth During the COVID-19 Pandemic	28
Abortion and Mental Health—Context and Common Ground	28
Prenatal Exposure to Nonpersistent Environmental Chemicals and Postpartum Depression	28
Mental Health Impairment and Outpatient Mental Health Care of US Children and Adolescents	28
Effectiveness, Core Elements, and Moderators of Response of Cognitive Remediation for Schizophrenia	28
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression Among Adults in the US Veterans Affairs Health Care System	28
Concerns Regarding Strength of Conclusions in Systematic Review and Meta-Analysis of Neuroradiological Abnormalities in First-Episode Psychosis—Reply	28
US Veterans Affairs and Department of Defense 2023 Clinical Guideline for PTSD—Devolving Not Evolving	28
Sex-Specific Pathways From Prenatal Maternal Inflammation to Adolescent Depressive Symptoms	28
Long-term Exposure to Multiple Ambient Air Pollutants and Association With Incident Depression and Anxiety	28
Capturing the Full Range of Buprenorphine Treatment Response	27
Informed Consent to Psychedelic Treatment—A Work in Progress	27
Evaluation of the Risk Identification for Suicide and Enhanced Care Model in a Native American Community	27
Errors in Figures 1 and 2	26
JAMA Psychiatry	26
Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans	26
Effectiveness of Resource Groups for Improving Empowerment, Quality of Life, and Functioning of People With Severe Mental Illness	26
Error in Results and in the Figure 3B Label and Plotted Values	26
JAMA Psychiatry Editorial Fellow	26
Perinatal Depression Screening Among Sexual Minority Women	25
Long-term Arrhythmia Detection Using an Implantable Loop Recorder in Patients Receiving Psychotropic Medication	25
Association of Major Disease Outbreaks With Adolescent and Youth Mental Health in Low- and Middle-Income Countries	25
Errors in Statistical Results	25
Climate Change and Mental Health—Time to Act Now	25
Estimated Average Treatment Effect of Psychiatric Hospitalization in Patients With Suicidal Behaviors	25
Examining Power Relations to Understand and Address Social Determinants of Vaccine Uptake	25
Numerical Error in Results of Abstract and Article Text	25
Psychopharmacology and Explanatory Pluralism	24
JAMA Psychiatry Peer Reviewers in 2021	24
Association Between Physical Activity and Schizophrenia	24
Change to Open Access Status	23
Error in Results	23
Susceptibility to Treatment-Resistant Depression Within Families	23
JAMA Psychiatry	23
Error in the Caption of Figures 2, 3, 4, and 5 and in Supplement 1	23
Characterizing and Coding Psychiatric Diagnoses Using Electronic Health Record Data	23
Associations of Changes in Sleep and Emotional and Behavioral Problems From Late Childhood to Early Adolescence	23
Now Is the Time to Support Black Individuals in the US Living With Serious Mental Illness—A Call to Action	22
The Direct Effect of Cognitive Behavioral Therapy for Insomnia on Depression Prevention and the Mediation Effect via Insomnia Remission—Reply	22
A Traitlike Dimension of Subjective Memory Concern Over 30 Years Among Adult Male Twins	22
Error in Byline	22
JAMA Psychiatry Editorial Fellow	22
Rural-Urban Disparities in Video Telehealth Use During Rapid Mental Health Care Virtualization Among American Indian/Alaska Native Veterans	22
Depressive Symptoms and Amyloid Pathology	21
Course of Subtypes of Late-Life Depression Identified by Bipartite Network Analysis During Psychosocial Interventions	21
Intergenerational Effects of Racism	21
Association Between Physical Activity and Risk of Depression	21
Bright Light Therapy for Nonseasonal Depressive Disorders	21
Errors in Data Set and Effect Sizes for 1 Study Included in Meta-analysis of Delay Discounting as a Transdiagnostic Process in Psychiatric Disorders	21
Treatment Outcomes With Licensed and Unlicensed Stimulant Doses for Adults With Attention-Deficit/Hyperactivity Disorder	20
Social Disconnection as a Global Behavioral Epidemic—A Call to Action About a Major Health Risk Factor	20
Estimated Prevalence of Perinatal Depression in Low- and Middle-Income Countries Considering Uncertainty of Test Properties—Reply	20
Mental Health Service Use Before First Diagnosis of a Psychotic Disorder	20
Maintenance of Wellness in Patients With Obsessive-Compulsive Disorder Who Discontinue Medication After Exposure/Response Prevention Augmentation	20
Digital Mental Health’s Unstable Dichotomy—Wellness and Health	20
Addiction Medicine Physicians and Medicinal Cannabinoids	19
Genes and Rearing—What Explains Intergenerational Transmission of PTSD?	19
Extrapharmacological Safety Topics in Psychedelic-Assisted Psychotherapy	19
Gabapentin Use Among Individuals Initiating Buprenorphine Treatment for Opioid Use Disorder	19
Data Pollution in Neuropsychiatry—An Under-Recognized but Critical Barrier to Research Progress	19
Perinatal Mental Health Outcomes Following Natural Disasters	19
Community-Level Social Support Infrastructure and Adult Onset of Major Depressive Disorder in a South Asian Postconflict Setting	19
Advancing the Blueprint to Mental Health Parity Reform	19
An Atlas of Genetic Correlations and Genetically Informed Associations Linking Psychiatric and Immune-Related Phenotypes	18
Contrasting Case-Control and Normative Reference Approaches to Capture Clinically Relevant Structural Brain Abnormalities in Patients With First-Episode Psychosis Who Are Antipsychotic Naive	18
Global Mental Health Services and the Impact of Artificial Intelligence–Powered Large Language Models	18
Risk for Mood, Anxiety, and Psychotic Disorders in Individuals at High and Low Genetic Liability for Bipolar Disorder and Major Depression	18
Evaluation of Post–COVID-19 Cognitive Dysfunction: Recommendations for Researchers	18
Methamphetamine Overdose Deaths in the US by Sex and Race and Ethnicity	18